House Phospho Banner
 

News:

Akt as a Target in Cancer Research

Date Posted:
2013-03-12

Research has shown Akt expression promotes many processes associated with malignant phenotypes, demonstrating that Akt activation can be a precursor to cancer. Akt signaling has been targeted to better determine the effects of cancer therapies and learn more about the disease on a cellular level. Rockland's Akt signaling antibodies are a crucial research tool and produce accurate, repeatable results in a variety of applications. To learn more, visit our Akt pathway or contact us today.

 

View the Full Newsletter